These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

145 related items for PubMed ID: 38886355

  • 41. Effect of a sustained reduction in plasma free fatty acid concentration on intramuscular long-chain fatty Acyl-CoAs and insulin action in type 2 diabetic patients.
    Bajaj M, Suraamornkul S, Romanelli A, Cline GW, Mandarino LJ, Shulman GI, DeFronzo RA.
    Diabetes; 2005 Nov; 54(11):3148-53. PubMed ID: 16249438
    [Abstract] [Full Text] [Related]

  • 42. Increased circulating granzyme B in type 2 diabetes patients with low-grade systemic inflammation.
    Cimini FA, D'Eliseo D, Barchetta I, Bertoccini L, Velotti F, Cavallo MG.
    Cytokine; 2019 Mar; 115():104-108. PubMed ID: 30473178
    [Abstract] [Full Text] [Related]

  • 43. Association between serum free fatty acid levels and nonalcoholic fatty liver disease: a cross-sectional study.
    Zhang J, Zhao Y, Xu C, Hong Y, Lu H, Wu J, Chen Y.
    Sci Rep; 2014 Jul 25; 4():5832. PubMed ID: 25060337
    [Abstract] [Full Text] [Related]

  • 44. Elevated concentrations of free fatty acids are associated with increased insulin response to standard glucose challenge in human immunodeficiency virus-infected subjects with fat redistribution.
    Meininger G, Hadigan C, Laposata M, Brown J, Rabe J, Louca J, Aliabadi N, Grinspoon S.
    Metabolism; 2002 Feb 25; 51(2):260-6. PubMed ID: 11833059
    [Abstract] [Full Text] [Related]

  • 45. Exposure to phthalates in patients with diabetes and its association with oxidative stress, adiponectin, and inflammatory cytokines.
    Duan Y, Wang L, Han L, Wang B, Sun H, Chen L, Zhu L, Luo Y.
    Environ Int; 2017 Dec 25; 109():53-63. PubMed ID: 28938100
    [Abstract] [Full Text] [Related]

  • 46. Higher fasting plasma free fatty acid levels are associated with lower insulin secretion in children and adults and a higher incidence of type 2 diabetes.
    Salgin B, Ong KK, Thankamony A, Emmett P, Wareham NJ, Dunger DB.
    J Clin Endocrinol Metab; 2012 Sep 25; 97(9):3302-9. PubMed ID: 22740706
    [Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50. Effect of gliclazide modified release on adiponectin, interleukin-6, and tumor necrosis factor-alpha plasma levels in individuals with type 2 diabetes mellitus.
    Drzewoski J, Zurawska-Klis M.
    Curr Med Res Opin; 2006 Oct 25; 22(10):1921-6. PubMed ID: 17022850
    [Abstract] [Full Text] [Related]

  • 51. Comparative evaluation of the therapeutic effect of metformin monotherapy with metformin and acupuncture combined therapy on weight loss and insulin sensitivity in diabetic patients.
    Firouzjaei A, Li GC, Wang N, Liu WX, Zhu BM.
    Nutr Diabetes; 2016 May 02; 6(5):e209. PubMed ID: 27136447
    [Abstract] [Full Text] [Related]

  • 52. Serum sphingolipids and inflammatory mediators in adolescents at risk for metabolic syndrome.
    Majumdar I, Mastrandrea LD.
    Endocrine; 2012 Jun 02; 41(3):442-9. PubMed ID: 22228496
    [Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55. Adipogenic risk factor differences between Korean and white adults--potential role of plasma free fatty acid and adiponectin.
    Lee S, Jensen MD.
    Metabolism; 2009 Feb 02; 58(2):270-4. PubMed ID: 19154962
    [Abstract] [Full Text] [Related]

  • 56. Twenty-four-hour profiles of plasma glucose, insulin, C-peptide and free fatty acid in subjects with varying degrees of glucose tolerance following short-term, medium-dose prednisone (20 mg/day) treatment: evidence for differing effects on insulin secretion and action.
    Yuen KC, McDaniel PA, Riddle MC.
    Clin Endocrinol (Oxf); 2012 Aug 02; 77(2):224-32. PubMed ID: 21973241
    [Abstract] [Full Text] [Related]

  • 57. No evidence of a synergistic effect of HIV infection and diabetes mellitus type 2 on fat distribution, plasma adiponectin or inflammatory markers.
    Hove-Skovsgaard M, Abildgaard J, Gelpi M, Gaardbo JC, Kolte L, Ullum H, Trøseid M, Lindegaard B, Nielsen SD.
    BMC Infect Dis; 2020 Nov 25; 20(1):882. PubMed ID: 33238950
    [Abstract] [Full Text] [Related]

  • 58. Lactation intensity and fasting plasma lipids, lipoproteins, non-esterified free fatty acids, leptin and adiponectin in postpartum women with recent gestational diabetes mellitus: the SWIFT cohort.
    Gunderson EP, Kim C, Quesenberry CP, Marcovina S, Walton D, Azevedo RA, Fox G, Elmasian C, Young S, Salvador N, Lum M, Crites Y, Lo JC, Ning X, Dewey KG.
    Metabolism; 2014 Jul 25; 63(7):941-50. PubMed ID: 24931281
    [Abstract] [Full Text] [Related]

  • 59. Subclinical Inflammation and Endothelial Dysfunction in Young Patients with Diabetes: A Study from United Arab Emirates.
    Aburawi EH, AlKaabi J, Zoubeidi T, Shehab A, Lessan N, Al Essa A, Yasin J, Saadi H, Souid AK.
    PLoS One; 2016 Jul 25; 11(7):e0159808. PubMed ID: 27459718
    [Abstract] [Full Text] [Related]

  • 60. Role of APN and TNF-α in type 2 diabetes mellitus complicated by nonalcoholic fatty liver disease.
    Lin X, Zhang Z, Chen JM, Xu YY, Ye HR, Cui J, Fang Y, Jin Y, Zhu DR, Yuan L.
    Genet Mol Res; 2015 Apr 10; 14(2):2940-6. PubMed ID: 25966055
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.